Search

Your search keyword '"Piaceri, Irene"' showing total 237 results

Search Constraints

Start Over You searched for: Author "Piaceri, Irene" Remove constraint Author: "Piaceri, Irene"
237 results on '"Piaceri, Irene"'

Search Results

1. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

2. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

3. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

4. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

5. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

7. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

9. Frontotemporal dementia and its subtypes: a genome-wide association study

10. C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

12. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

14. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

15. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

17. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

19. Data‐driven staging of genetic frontotemporal dementia using multi‐modal <scp>MRI</scp>

20. Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation

23. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited

24. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

25. MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia

28. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

31. A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia

33. Heterozygous TREM2 mutations in frontotemporal dementia

34. Challenges in Alzheimer’s Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences

35. Tumor Necrosis Factor α Influences Phenotypic Plasticity and Promotes Epigenetic Changes in Human Basal Forebrain Cholinergic Neuroblasts

36. Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer’s Disease in Subjective Cognitive Decline and Mild Cognitive Impairment Patients

38. Concordance among neuropsychological profile, functional neuroimaging and pathological biomarkers in Primary Progressive Aphasia. A single-centre experience (675)

39. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

44. Clinical and neuroimaging profiles to identify C9orf72 ‐FTD patients and serum Neurofilament to monitor the progression and the severity of the disease

45. Primary Progressive Aphasia

46. Alzheimer's Disease Progression : Factors Influencing Cognitive Decline

47. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations:a genome-wide association study

48. Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier

49. Analyses of the role of the glucocorticoid receptor gene polymorphism (rs41423247) as a potential moderator in the association between childhood overweight, psychopathology, and clinical outcomes in Eating Disorders patients: A 6 years follow up study

50. No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients

Catalog

Books, media, physical & digital resources